Alamar Biosciences, Inc. (California) (ALMR)

26.29 +1.01 (+4.00%) USD  |  NASDAQ  |  Oct 19, 15:33
More

Alamar Biosciences Cash from Operations (Annual) : -53.61M for Dec. 31, 2025

Cash from Operations (Annual) Chart

Historical Cash from Operations (Annual) Data

View and export this data back to 2024. Start Trial.
Date Value
December 31, 2025 -53.61M
Date Value
December 31, 2024 -55.21M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Personalis, Inc. -74.95M
10X Genomics, Inc. 136.05M
Champions Oncology, Inc. -4.472M
Medpace Holdings, Inc. 713.22M
Avantor, Inc. 623.80M